GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ace (ACE) [hlAlert]

Rating:
Overweight
ACE
down 7.70 %

Ace (ACE) rated Overweight by Morgan Stanley

Posted on: Thursday,  Nov 12, 2015  10:25 AM ET by Morgan Stanley

Morgan Stanley rated Overweight Ace (NYSE: ACE) on 11/12/2015, when the stock price was $112.29. Since
then, Ace has lost 7.70% as of 01/05/2016's recent price of $103.64.
If you would have followed this Morgan Stanley's recommendation on ACE, you would have lost 7.7% of your investment in 54 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2015 10:25 AM Buy
None
112.29
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy